Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
Get Alerts RPRX Hot Sheet
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walgreens Boots Alliance (WBA) Tops Q2 EPS by 38c, Offers Guidance
- Sprinklr (CXM) Tops Q4 EPS by 4c; offers guidance
- China Automotive Systems (CAAS) Tops Q4 EPS by 24c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!